Nemluvio was well tolerated and showed sustained improvements in moderate to severe prurigo nodularis during a 2-year ...

First, the good news: While food poisoning symptoms can linger for up to a week, Dr. Dasgupta says most cases clear up in a ...

©News Group Newspapers Limited in England No. 679215 Registered office: 1 London Bridge Street, London, SE1 9GF. "The Sun", ...

Norovirus causes an average of 900 deaths annually mostly among older adults, 109,000 hospitalizations, and 19 million to 21 million cases in the U.S. each year.

A dreaded fungus known to inhabit tombs has been reconstituted as a treatment for leukemia and is performing as effectively ...

Vermont has the second lowest state fatality rate in the US (147.9 per 100K; Hawaii 113.5/100K). Mississippi (465.6/100K) and ...

Kylian Mbappe of Real Madrid has been hospitalized with acute gastroenteritis, a significant blow to both the team and the inaugural tournament. The i ...

The International Agency for Research on Cancer classifies alcohol as a carcinogen, with new evidence connecting it to ...

Cocrystal plans to initiate a human norovirus challenge study in 2025 in the U.S. to evaluate CDI-988 as a potential prevention and treatment of norovirus infection.

On January 8, 2025, Cocrystal Pharma, Inc. (NASDAQ:COCP) announced results from the Phase 1 trial of CDI-988 for the prophylaxis and treatment of norovirus, coronavirus, and other viral infections.

The finding could lead to the design of broadly effective norovirus vaccine, as well as the development of new therapeutic antibodies for the treatment of norovirus-associated gastroenteritis. Share: ...

Research identifies key antibodies for development of broadly protective norovirus vaccine Discovery brings us one step closer to vaccine and treatment for prevalent virus. Peer-Reviewed Publication ...